Brief: Biocartis Starts Commercialization In Europe Of Merlin Assay
01/09/2022 06:06
Sept 1 (Reuters) - Biocartis Group NV BCART.BR :
* BIOCARTIS INITIATES COMMERCIALIZATION IN EUROPE OF
SKYLINEDX'S
INNOVATIVE MERLIN™ASSAY(CE-IVD) FOR MELANOMA PATIENTS
Source text for Eikon: ID:nGNE6Whv9S
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies